Karmanos Cancer Institute

The Barbara Ann Karmanos Cancer Institute and Wayne State University present the annual Head and Neck Cancer Symposium on Saturday, Nov. 8, 2025, from 7:30 a.m. to 2:30 p.m. at the Detroit Marriott Troy (200 W. Big Beaver Road, Troy, Michigan). This year’s symposium features two guest speakers. Robert Haddad, M.D. , professor of Medicine, chief of the Division of Head and Neck Oncology, McGraw Chair in Head and Neck Oncology at Dana Farber Cancer Institute and Harvard Medical School in Boston, will deli...

Hour Detroit’s 2025 Top Docs List  is out; over 80 physicians from the  Barbara Ann Karmanos Cancer Institute  are listed. This year’s magazine also features a Karmanos physician on the cover. Each year, Hour Detroit Magazine puts out an online peer-to-peer review survey conducted by Professional Research Services (PRS) to determine the top physicians in southeastern Michigan. Participating physicians in Livingston, Macomb, Oakland, Washtenaw, and Wayne Counties nominate the best doctors ...

On Friday, Oct. 3, 2025, the Barbara Ann Karmanos Cancer Institute and Wayne State University will host the Annual Gastrointestinal Oncology Symposium , which will bring together some of the nation’s most respected leaders in gastrointestinal and neuroendocrine oncology for a day of leading-edge science, practical insights and collaborative discussion. “We provide this conference each year, and we collectively try to gather updates happening in gastrointestinal oncology from around the world,” explained...

The  Barbara Ann Karmanos Cancer Institute  is pleased to welcome four doctoral-level biomedical data scientists who have joined as members of the Biostatistics and Bioinformatics Core in 2024 and 2025. Yang Shi, Ph.D. , joined Karmanos as co-scientific director of the Biostatistics and Bioinformatics Core in July 2024 and as an assistant professor in the Department of Oncology at Wayne State University (WSU) School of Medicine. Dr. Shi received his Ph.D. in biostatistics from the University o...

Researchers at the Barbara Ann Karmanos Cancer Institute and Wayne State University (WSU) have developed a chemical imaging probe that resists the breakdown of certain compounds in the body, giving doctors a more dependable way to track and potentially treat prostate cancer. Sheryl Roberts, Ph.D., member of the Karmanos Molecular Therapeutics Program and assistant professor at WSU School of Medicine ,  is the study’s principal investigator. The National Cancer Institute lists prostate cancer as the...

Physician specializes in stem cell transplantation for blood cancers   The Barbara Ann Karmanos Cancer Institute welcomes Bradley Rockwell, M.D. , transplant hematologist. Dr. Rockwell is a member of the Bone Marrow and Stem Cell Transplant , Hematology Oncology and Multiple Myeloma and Amyloidosis Multidisciplinary Teams at Karmanos. He specializes in bone marrow transplants and treating leukemia, lymphoma, multiple myeloma, myelodysplasia, and non-Hodgkin lymphoma. He began seeing patients at the...

Fedoronko has extensive expertise in oncology nursing, having worked at Karmanos for over two decades   The Barbara Ann Karmanos Cancer Institute names Kathleen Fedoronko, MSN, RN, OCN, as the new chief nursing officer and vice president of Patient Care Services at Karmanos Cancer Hospital. Fedoronko brings over 25 years of ambulatory and acute health care leadership, 20 of those years at Karmanos. She assumed the position in June after Kathleen Carolin, RN, BSN, MSA, the former CNO, retired. “I’ve...

New state-of-the-art facility to transform research, innovation and community health in Detroit; Hub for discovery to accelerate research impact and provide College of Career experiences for WSU students Wayne State University (WSU) marked a major milestone in its mission to advance health and scientific discovery with the groundbreaking of the Health Sciences Research Building (HSRB) on Tuesday, Sept. 9, 2025. This transformative, $200 million, 160,000-square-foot facility will drive next-generation op...

Meet Karmanos: Bone Marrow and Stem Cell Transplant Program

For Gen Sheng Wu, Ph.D., a member of the Molecular Therapeutics Research Program at the Barbara Ann Karmanos Cancer Institute and professor in the Department of Oncology and Pathology at Wayne State University School of Medicine, witnessing the research he began 20 years ago lead to a newly approved cancer treatment is a dream come true. ONC201, now renamed dordaviprone (ModeysoTM), was approved by the U.S. Food and Drug Administration (FDA) on August 6, 2025, to treat a rare and aggressive brain cancer...